SCHEMBL7259346

SCHEMBL7259346

COC(=O)c1ccc2[nH]c(C(=O)CC3CCCCN3)cc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYGL P06737 4/20 0.42
PYGM P11217 1/20 0.42
HRH3 Q9Y5N1 1/20 0.41
MMP2 P08253 1/20 0.41
MMP13 P45452 1/20 0.41
MAOB P27338 1/20 0.41
XDH P47989 2/20 0.39
MAPKAPK2 P49137 1/20 0.39
MLLT1 Q03111 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NAMPT P43490 1/20 0.37
KIF11 P52732 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21848527 0.76 KHK (0.45) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL454902 0.76 MAOB (0.64) HRH3MAOBKDM4EALDH1A1HPGD
SCHEMBL30694751 0.75 XDH (0.61) PYGLPYGMHRH3MMP2MMP13
SCHEMBL3240597 0.72 HRH3 (0.59) PYGLPYGMHRH3MMP2MMP13
SCHEMBL13386801 0.71 MMP2 (0.60) PYGLPYGMHRH3MMP2MMP13
SCHEMBL15571271 0.70 POLB (0.55) ALDH1A1NPC1SMN1; SMN2
SCHEMBL15683130 0.68 CREBBP (0.50) HRH3MMP2MMP13XDHMEN1
SCHEMBL30047012 0.68 HRH3 (0.51) PYGLPYGMHRH3MMP2MMP13
SCHEMBL3246114 0.68 HRH3 (0.51) PYGLPYGMHRH3MMP2MMP13
SCHEMBL19720917 0.68 TLR9 (0.45) PYGLPYGMMAPKAPK2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003051871-A1 N-AROYL CYCLIC AMINE DERIVATIVES AND THEIR USE AS ORXIN RECEPTOR ANTAGONIST SMITHKLINE BEECHAM PLC (GB) 2003-06-26 WO disclosed